Search research articles
Contact Us
Filters
Showing results (331-340 of 344) with videos related to
Page
of 35
Sort By:
ACS Medicinal Chemistry Letters
|
March 18, 2016
Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical Trials
T G Murali Dhar, Hai-Yun Xiao, Jenny Xie, et al.
Medchemcomm
|
August 16, 2018
Identification of potent tricyclic prodrug S1P<sub>1</sub> receptor modulators
David Marcoux, Hai-Yun Xiao, T G Murali Dhar, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 12, 2014
Identification of 1-{2-[4-chloro-1'-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4'-piperidine]-1-yl]phenyl}-3-{5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y(1) antagonist as an antiplatelet agent
Yoon T Jeon, Wu Yang, Jennifer X Qiao, et al.
Plos One
|
January 14, 2021
Diminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activity
Jason Ptacek, Rachael E Hawtin, Dongmei Sun, et al.
Journal of Medicinal Chemistry
|
February 21, 2019
Identification and Preclinical Pharmacology of ((1 R,3 S)-1-Amino-3-(( S)-6-(2-methoxyphenethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986166): A Differentiated Sphingosine-1-phosphate Receptor 1 (S1P<sub>1</sub>) Modulator Advanced into Clinical Trials
John L Gilmore, Hai-Yun Xiao, T G Murali Dhar, et al.
Frontiers in Immunology
|
March 8, 2024
IL11-mediated stromal cell activation may not be the master regulator of pro-fibrotic signaling downstream of TGFβ
Yunhao Tan, Kenta Mosallanejad, Qingxiu Zhang, et al.
Journal of Medicinal Chemistry
|
February 26, 2014
The discovery of asunaprevir (BMS-650032), an orally efficacious NS3 protease inhibitor for the treatment of hepatitis C virus infection
Paul M Scola, Li-Qiang Sun, Alan Xiangdong Wang, et al.
Journal of Medicinal Chemistry
|
February 22, 2014
Discovery and early clinical evaluation of BMS-605339, a potent and orally efficacious tripeptidic acylsulfonamide NS3 protease inhibitor for the treatment of hepatitis C virus infection
Paul M Scola, Alan Xiangdong Wang, Andrew C Good, et al.
Journal of Medicinal Chemistry
|
August 27, 2016
Discovery of a Potent Acyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus NS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily Dosing
Li-Qiang Sun, Eric Mull, Barbara Zheng, et al.
Journal of Medicinal Chemistry
|
May 26, 2017
Identification of a Potent, Selective, and Efficacious Phosphatidylinositol 3-Kinase δ (PI3Kδ) Inhibitor for the Treatment of Immunological Disorders
Qingjie Liu, Qing Shi, David Marcoux, et al.
Page
of 35
Search research articles
Search
Showing results (331-340 of 344) with videos related to
Sort By:
Page
of 35
ACS Medicinal Chemistry Letters
|
March 18, 2016
Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical Trials
T G Murali Dhar, Hai-Yun Xiao, Jenny Xie, et al.
Medchemcomm
|
August 16, 2018
Identification of potent tricyclic prodrug S1P<sub>1</sub> receptor modulators
David Marcoux, Hai-Yun Xiao, T G Murali Dhar, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 12, 2014
Identification of 1-{2-[4-chloro-1'-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4'-piperidine]-1-yl]phenyl}-3-{5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y(1) antagonist as an antiplatelet agent
Yoon T Jeon, Wu Yang, Jennifer X Qiao, et al.
Plos One
|
January 14, 2021
Diminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activity
Jason Ptacek, Rachael E Hawtin, Dongmei Sun, et al.
Journal of Medicinal Chemistry
|
February 21, 2019
Identification and Preclinical Pharmacology of ((1 R,3 S)-1-Amino-3-(( S)-6-(2-methoxyphenethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986166): A Differentiated Sphingosine-1-phosphate Receptor 1 (S1P<sub>1</sub>) Modulator Advanced into Clinical Trials
John L Gilmore, Hai-Yun Xiao, T G Murali Dhar, et al.
Frontiers in Immunology
|
March 8, 2024
IL11-mediated stromal cell activation may not be the master regulator of pro-fibrotic signaling downstream of TGFβ
Yunhao Tan, Kenta Mosallanejad, Qingxiu Zhang, et al.
Journal of Medicinal Chemistry
|
February 26, 2014
The discovery of asunaprevir (BMS-650032), an orally efficacious NS3 protease inhibitor for the treatment of hepatitis C virus infection
Paul M Scola, Li-Qiang Sun, Alan Xiangdong Wang, et al.
Journal of Medicinal Chemistry
|
February 22, 2014
Discovery and early clinical evaluation of BMS-605339, a potent and orally efficacious tripeptidic acylsulfonamide NS3 protease inhibitor for the treatment of hepatitis C virus infection
Paul M Scola, Alan Xiangdong Wang, Andrew C Good, et al.
Journal of Medicinal Chemistry
|
August 27, 2016
Discovery of a Potent Acyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus NS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily Dosing
Li-Qiang Sun, Eric Mull, Barbara Zheng, et al.
Journal of Medicinal Chemistry
|
May 26, 2017
Identification of a Potent, Selective, and Efficacious Phosphatidylinositol 3-Kinase δ (PI3Kδ) Inhibitor for the Treatment of Immunological Disorders
Qingjie Liu, Qing Shi, David Marcoux, et al.
Page
of 35